A National Biotechnology Agency in Asia

The biotechnology agency sought to accelerate the growth of domestic biotech SMEs by facilitating international technology acquisition, IP auditing, and venture mentorship. The leadership sought an authoritative, independent strategic evaluation to optimize grant allocation mechanisms, streamline technology transfer workflows, and align regional innovation policies with global best practices.

Oxford Oracle delivered a comprehensive SME Acceleration Programme, auditing 20 high-potential biotech companies, conducting IP due diligence, and structuring international commercialisation roadmaps. Oxford Oracle deployed a multidisciplinary advisory team to execute comprehensive technical due diligence, design bespoke commercialisation roadmaps, and establish standardized stage-gate evaluation metrics. This comprehensive initiative significantly accelerated time-to-market for novel inventions while safeguarding core institutional IP rights and fostering regional economic growth.

Participating biotech SMEs expanded into 5 international markets, raised £6.4 million in private venture co-investment, and registered 12 new international patents within 24 months. Furthermore, the engagement established a permanent, scalable operational blueprint, driving long-term strategic alignment, continuous revenue growth, and enhanced institutional reputation across global innovation networks.